close
close

GSK places more Zantac-Rechtsstreit bei

GSK places more Zantac-Rechtsstreit bei

DJ GSK Explains Zantac’s Right-Way Strategy to Helena Smolak LONDON (Dow Jones) – British pharmaceutical group GSK, headquartered in the US, has a different story about the market for zurückgezogene Medikament …